These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38844774)

  • 21. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
    Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
    Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
    Regauer S; Kashofer K; Reich O
    Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma.
    Kortekaas KE; Solleveld-Westerink N; Tessier-Cloutier B; Rutten TA; Poelgeest MIE; Gilks CB; Hoang LN; Bosse T
    Histopathology; 2020 Jul; 77(1):92-99. PubMed ID: 32236967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.
    Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP
    Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma.
    Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
    Clancy AA; Spaans JN; Weberpals JI
    Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of vulvar squamous cell carcinoma in Japanese women.
    Osakabe M; Hayashi M; Katayama Y; Emura I; Nemoto K; Umezu H; Saitoh K; Motoyama T
    Pathol Int; 2007 Jun; 57(6):322-7. PubMed ID: 17539962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome.
    Gordinier ME; Schau GF; Pollock SB; Shields LBE; Talwalkar S
    Gynecol Oncol; 2024 Jan; 180():111-117. PubMed ID: 38086165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
    Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A
    Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the Vulva.
    Pors J; Tessier-Cloutier B; Thompson E; Almadani N; Ho J; Gilks B; Huntsman D; Hoang L
    Int J Gynecol Pathol; 2021 Jul; 40(4):391-399. PubMed ID: 33323855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
    Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
    J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
    Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.
    Han MR; Shin S; Park HC; Kim MS; Lee SH; Jung SH; Song SY; Lee SH; Chung YJ
    Exp Mol Med; 2018 Feb; 50(2):e442. PubMed ID: 29422544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer.
    Vanin K; Scurry J; Thorne H; Yuen K; Ramsay RG
    J Invest Dermatol; 2002 Nov; 119(5):1027-33. PubMed ID: 12445188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
    Corey L; Wallbillich JJ; Wu S; Farrell A; Hodges K; Xiu J; Nabhan C; Guastella A; Kheil M; Gogoi R; Winer I; Bandyopadhyay S; Huang M; Jones N; Wilhite A; Karnezis A; Thaker P; Herzog TJ; Oberley M; Korn WM; Vezina A; Morris R; Ali-Fehmi R
    Int J Gynecol Pathol; 2023 Sep; 42(5):515-522. PubMed ID: 37131274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.